European Healthtech startup funding raised during H2 2016.
In H2 2016, 172 European Healthtech companies raised a combined €916M across 180 funding rounds, down 34.4% versus H2 2015. Ireland led by capital raised, and Bpifrance was the most active investor. Data as of 23 Aug 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Carrick Therapeutics | Series A | Oct 2016 | €86M |
| NaPopravku | Early VC | Dec 2016 | €46M |
| Brillen.de | Growth/Late | Jul 2016 | €45M |
| IOmx Therapeutics | Series A |
16 exits · €124M disclosed.
| Creo Medical | IPO | Jul 2016 | €74M |
| Genesort | Acquisition | Dec 2016 | €21M |
| Luck Genome | Acquisition | Oct 2016 | €11M |
| Cellink | IPO | Aug 2016 | €8.1M |
| Linkcare | Acquisition | Oct 2016 | €5.0M |
| dariohealth | IPO | Nov 2016 | €4.6M |
| Sep 2016 |
| €40M |
| Genomics Medicine Ireland | Series A | Oct 2016 | €36M |
| Genfit | Growth/Late | Oct 2016 | €34M |
| BONESUPPORT | Growth/Late | Oct 2016 | €33M |
| OxThera | Other | Nov 2016 | €32M |
| Spineart | Growth/Late | Sep 2016 | €30M |
| Artios | Series A | Sep 2016 | €29M |
| NBE-Therapeutics | Series B | Nov 2016 | €19M |
| Cambridge Medical Robotics | Series A | Jul 2016 | €18M |
| Aspect Imaging | Growth/Late | Jul 2016 | €18M |
| Nyxoah | Series B | Jul 2016 | €18M |
| Vivasure Medical | Series C | Sep 2016 | €16M |